statistiche ricercatore

Continente	#
NA - Nord America	393
AS - Asia	309
SA - Sud America	87
EU - Europa	77
Continente sconosciuto - Info sul continente non disponibili	9
AF - Africa	7
OC - Oceania	1
Totale	883

Nazione	#
US - Stati Uniti d'America	375
SG - Singapore	135
BR - Brasile	65
CN - Cina	62
VN - Vietnam	37
HK - Hong Kong	27
IN - India	17
IT - Italia	16
FI - Finlandia	14
GB - Regno Unito	10
AR - Argentina	9
BD - Bangladesh	7
CA - Canada	7
FR - Francia	7
DE - Germania	6
IE - Irlanda	5
ID - Indonesia	4
MX - Messico	4
CL - Cile	3
CO - Colombia	3
DO - Repubblica Dominicana	3
IQ - Iraq	3
RU - Federazione Russa	3
UA - Ucraina	3
AE - Emirati Arabi Uniti	2
BE - Belgio	2
EC - Ecuador	2
JP - Giappone	2
KG - Kirghizistan	2
LT - Lituania	2
NL - Olanda	2
PE - Perù	2
PL - Polonia	2
SE - Svezia	2
SV - El Salvador	2
ZA - Sudafrica	2
AZ - Azerbaigian	1
BY - Bielorussia	1
CG - Congo	1
EG - Egitto	1
GR - Grecia	1
JM - Giamaica	1
JO - Giordania	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
MA - Marocco	1
MN - Mongolia	1
MY - Malesia	1
NP - Nepal	1
NR - Nauru	1
PH - Filippine	1
PK - Pakistan	1
PR - Porto Rico	1
PY - Paraguay	1
SA - Arabia Saudita	1
SI - Slovenia	1
SN - Senegal	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
UY - Uruguay	1
VE - Venezuela	1
Totale	874

Nome	#
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019	131
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33	97
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity	95
Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB	91
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy	73
Optimization of a Luciferase-Expressing Non-Invasive Intrapleural Model of Malignant Mesothelioma in Immunocompetent Mice	71
Tumor-Associated Macrophages: toward a better understanding of their cancer driver capability in Malignant Pleural Mesothelioma	67
Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment	63
Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma	54
The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset	49
Macrophages and cancer stem cells: a malevolent alliance	49
Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing	43
Totale	883

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	10	0	0	0	0	0	0	0	0	0	0	0	10
2022/2023	32	6	0	4	1	3	2	0	3	4	4	5	0
2023/2024	58	5	5	8	3	2	12	9	2	1	0	5	6
2024/2025	175	1	0	3	2	8	33	8	10	23	47	19	21
2025/2026	544	58	73	54	38	12	34	97	44	31	46	28	29
2026/2027	64	29	35	0	0	0	0	0	0	0	0	0	0
Totale													883